|People who read this document also read:|
|Global Immune Technologies Inc. - 10-K, Annual Report|
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 9, 2011
VONAGE HOLDINGS CORP.
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction
|23 Main Street, Holmdel, NJ||07733|
|(Address of Principal Executive Offices)||(Zip Code)|
Registrants telephone number, including area code: (732) 528-2600
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
|Item 5.07||Submission of Matters to a Vote of Security Holders.|
The Company held its 2011 Annual Meeting of Stockholders on June 9, 2011. There were present at the Annual Meeting in person or by proxy stockholders holding an aggregate of 203,901,977 shares of common stock.
The results of the vote taken at the Annual Meeting with respect to the election of the nominees to be Class II Directors and a Class I Director, as applicable, were as follows:
|Class II Director Nominees||Votes For||Votes
Marc P. Lefar
John J. Roberts
Joseph M. Redling
|Class I Director Nominee||Votes For||Votes
David C. Nagel
The terms of the following directors, who were not up for re-election at the Annual Meeting, will continue: Peter Barris, Michael A. Krupka, Jeffrey A. Citron, Morton David, and Jeffrey J. Misner.
The appointment of BDO USA, LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2011 was ratified with 203,127,014 votes in favor, 700,078 votes against, and 74,885 abstentions. There were no broker non-votes.
The non-binding advisory vote on the Companys executive compensation was approved, with 129,926,104 votes in favor, 43,633,461 votes against, 87,475 abstentions, and 30,254,937 broker non-votes.
The non-binding advisory vote on the frequency of advisory votes on the Companys executive compensation was as follows: 72,948,641 votes for one year; 342,063 votes for two years; 99,971,175 votes for three years; 385,161 abstentions, and 30,254,937 broker non-votes. On June 9, 2011, following the annual meeting, the Companys board of directors determined, consistent with the stockholder advisory vote, that future advisory votes on the Companys executive compensation will be held every three years.
- 2 -
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|VONAGE HOLDINGS CORP.|
|Date: June 9, 2011||By:|
|Kurt M. Rogers|
|Chief Legal Officer and Secretary|
- 3 -